Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1481-1490 of 1,553) with videos related to

Pageof 156
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Kohei Shitara, Florian Lordick, et al.
The Lancet. Oncology|September 23, 2020
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 studyJianming Xu, Lin Shen, Chunmei Bai, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
MDR reversal activity of bromotetrandrine in vitro and in vivoJian Cheng, Jue-Qiong Wang, Bao-An Chen, et al.
Nature Medicine|July 10, 2025
A bispecific antibody-drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trialChang Liu, Dan Liu, Yinghua Ji, et al.
The New England Journal of Medicine|June 2, 2025
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric CancerKohei Shitara, Eric Van Cutsem, Mahmut Gümüş, et al.
Oncogene|July 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subsetJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Nanomaterials (Basel, Switzerland)|April 7, 2017
Breakthrough to Non-Vacuum Deposition of Single-Crystal, Ultra-Thin, Homogeneous Nanoparticle Layers: A Better Alternative to Chemical Bath Deposition and Atomic Layer DepositionYu-Kuang Liao, Yung-Tsung Liu, Dan-Hua Hsieh, et al.
Cancer Medicine|July 12, 2019
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasmsYu Zhang, Liang Shang, Pan-Pan Zhang, et al.
Pageof 156

Showing results (1481-1490 of 1,553) with videos related to

Sort By:
Pageof 156
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Kohei Shitara, Florian Lordick, et al.
The Lancet. Oncology|September 23, 2020
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 studyJianming Xu, Lin Shen, Chunmei Bai, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
MDR reversal activity of bromotetrandrine in vitro and in vivoJian Cheng, Jue-Qiong Wang, Bao-An Chen, et al.
Nature Medicine|July 10, 2025
A bispecific antibody-drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trialChang Liu, Dan Liu, Yinghua Ji, et al.
The New England Journal of Medicine|June 2, 2025
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric CancerKohei Shitara, Eric Van Cutsem, Mahmut Gümüş, et al.
Oncogene|July 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subsetJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Nanomaterials (Basel, Switzerland)|April 7, 2017
Breakthrough to Non-Vacuum Deposition of Single-Crystal, Ultra-Thin, Homogeneous Nanoparticle Layers: A Better Alternative to Chemical Bath Deposition and Atomic Layer DepositionYu-Kuang Liao, Yung-Tsung Liu, Dan-Hua Hsieh, et al.
Cancer Medicine|July 12, 2019
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasmsYu Zhang, Liang Shang, Pan-Pan Zhang, et al.
Pageof 156